Famvir for Treatment of Hearing in Unilateral Meniere's Disease
Status:
Terminated
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
The specific aim of this study is to determine the efficacy of treatment with famciclovir in
unilateral Meniere's Disease patients, specifically whether hearing can be improved. The
investigators will determine the percentage of unilateral Meniere's Disease patients
experiencing an absence of hearing fluctuation after 3 months of treatment with famciclovir
as compared to the placebo arm.